BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15715161)

  • 21. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea.
    Park YK; Shin S; Ryu S; Cho SN; Koh WJ; Kwon OJ; Shim YS; Lew WJ; Bai GH
    J Microbiol Methods; 2005 Nov; 63(2):165-72. PubMed ID: 15893392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the mutations in katG 315 and inhA -15 of Mycobacterium tuberculosis strains isolated from Chinese patients.
    Wu XQ; Lu Y; Zhang JX; Liang JQ; Li HM; Zhang GY; Lü CH; Ding BC
    Chin Med J (Engl); 2006 Feb; 119(3):230-3. PubMed ID: 16537011
    [No Abstract]   [Full Text] [Related]  

  • 23. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa.
    Johnson R; Warren R; Strauss OJ; Jordaan AM; Falmer AA; Beyers N; Schaaf HS; Murray M; Cloete K; van Helden PD; Victor TC
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1412-4. PubMed ID: 17167961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates.
    Tracevska T; Jansone I; Baumanis V; Marga O; Lillebaek T
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1097-103. PubMed ID: 14598971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-resistant tuberculosis presenting as a solitary splenic mass in an immunocompetent patient.
    Rojo A; Ibáñez MA; Alonso CA; Portillo ME; Quintana J; Yuste JR; Del Pozo JL
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):522-4. PubMed ID: 21767708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative molecular study of Mycobacterium tuberculosis strains, in times of antimicrobial drug resistance.
    Varela G; Carvajales S; Gadea P; Sirok A; Grotiuz G; Mota MI; Ritacco V; Reniero A; Rivas C; Schelotto F
    Rev Argent Microbiol; 2005; 37(1):11-5. PubMed ID: 15991474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
    Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis.
    Brown TJ; Herrera-Leon L; Anthony RM; Drobniewski FA
    J Microbiol Methods; 2006 May; 65(2):294-300. PubMed ID: 16153726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Nusrath Unissa A; Selvakumar N; Narayanan S; Narayanan PR
    Int J Antimicrob Agents; 2008 Jan; 31(1):71-5. PubMed ID: 18006278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
    Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):328-32. PubMed ID: 15786899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiological features of Mycobacterium tuberculosis in an endemic region of Henan Province, China.
    Li H; Yang HY; Ma XG; Ma SW; Zhang Y
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1097-9. PubMed ID: 22687267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on molecular epidemiology of Mycobacterium tuberculosis in Chinese army with PCR amplified fingerprinting methods].
    Zeng NH; Wang ZB; Tang BH; Xiao H; Wang SS; Li XG; Huang JL; Jiang PL; Wu CG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):377-80. PubMed ID: 12820931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characterization of the drug resistance spectrum of rifampicin-resistant M. tuberculosis to other first-line antituberculous drugs].
    Isakova ZhT; Goncharova ZK; Aldashev AA
    Probl Tuberk Bolezn Legk; 2008; (11):39-42. PubMed ID: 19140379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic marking of polyresistant mycobacterium tuberculosis strains isolated in the north-west of Russia].
    Narvskaia OV; Mokrousov IV; Otten TF; Vishnevskiĭ BI
    Probl Tuberk; 1999; (3):39-41. PubMed ID: 10420767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetic characteristics of rifampicin-resistant Mycobacterium tuberculosis isolates in Novosibirsk].
    Norkina OV; Filipenko ML; Nikonova AA; Kinsht VN; Kurunov IuN; Krasnov VA; Tat'kov SI
    Probl Tuberk Bolezn Legk; 2003; (12):22-5. PubMed ID: 15004967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile].
    Araya P; Velasco M; Tognarelli J; Arias F; Leiva T; Sccapatticio A; Alviz P; Fernández J
    Rev Med Chil; 2011 Apr; 139(4):467-73. PubMed ID: 21879185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
    Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA
    Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.